newsfilter
← Latest News
GlobeNewswire·

PharmaTher Provides Update on FDA New Drug Application for Ketamine

TORONTO, Feb. 12, 2025 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the "Company" or "PharmaTher") (OTCQB:PHRRF) (CSE:PHRM), a specialty pharmaceutical company seeking FDA approval for ketamine, today announced that